scorecardresearch
Follow Us:
Sunday, November 29, 2020

AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continue

Oxford confirmed the plan to keep testing, saying in a statement that after careful assessment "there have been no concerns about safety of the clinical trial."

By: Reuters | Sao Paolo | October 21, 2020 11:53:20 pm
covid vaccine, covid vaccine Serum Institute of India, covid vaccine Serum Institute, Serum Institute covid vaccine, covid vaccine India, India covid vaccine, India news, Indian ExpressBritain has ordered a total of 350 million doses of the vaccines in development, including 40 million shots of Pfizer's jab.

Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue.

Oxford confirmed the plan to keep testing, saying in a statement that after careful assessment “there have been no concerns about safety of the clinical trial.”

Brazilian newspaper O Globo reported that the volunteer had been given a placebo and not the trial vaccine, citing unnamed sources. Anvisa provided no further details, citing medical confidentiality of those involved in trials. AstraZeneca declined immediate comment.

The Federal University of Sao Paulo, which is helping coordinate phase 3 clinical trials in Brazil, separately said the volunteer was Brazilian without revealing where the person lived.

AstraZeneca shares fell 1.7%. The federal government has plans to purchase the UK vaccine and produce it at its biomedical research center FioCruz in Rio de Janeiro, while a competing vaccine from China’s Sinovac Biotech Ltd is being tested by Sao Paulo state’s research center Butantan Institute.

Brazil has the second deadliest outbreak of coronavirus, with more than 154,000 killed by COVID-19, following the United States. It has the third largest number of cases, with more than 5.2 million infected, after the United States and India.

📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest World News, download Indian Express App.

0 Comment(s) *
* The moderation of comments is automated and not cleared manually by indianexpress.com.
Advertisement
Advertisement
Advertisement
Advertisement